Literature DB >> 17057203

Synergistic costimulation by both B7 molecules regulates colitis pathogenesis.

Gisen Kim1, Stephen P Schoenberger, Arlene Sharpe, Mitchell Kronenberg.   

Abstract

It has been reported that B7-1 and B7-2 play different roles in the pathogenesis of autoimmunity, but this issue is controversial. Here we analyzed colitis induced by transfer of CD45RB(high) CD4+ T cells to immune-deficient recipients that lack expression of either B7-1 or B7-2. Surprisingly, disease was greatly accelerated in Rag(-/-) recipients deficient for either B7 molecule. Antigen presenting cells (APCs) lacking B7-1 or B7-2 stimulated T cell proliferation in vitro, but caused suboptimal IL-2 production, leading to decreased induction of CTLA-4. The data suggest that regulatory T cells function relatively normally in B7 single-deficient recipients, but they cannot restrain the increased pathogenesis by naïve cells primed in B7 single-deficient mice. Therefore, the inhibitory effect of CTLA-4 on pathogenic T cells likely slows colitis, even in the absence of regulatory T cells. While a full block of costimulation may prevent autoimmunity, our data indicate, surprisingly, that a partial block may in some cases augment disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17057203     DOI: 10.1196/annals.1326.012

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  2 in total

Review 1.  Costimulation of Th17 cells: Adding fuel or putting out the fire in the inflamed gut?

Authors:  Zili Zhang; James T Rosenbaum; Wenwei Zhong; Carmen Lim; David J Hinrichs
Journal:  Semin Immunopathol       Date:  2010-01-30       Impact factor: 9.623

2.  Prevention of Injury-Induced Osteoarthritis in Rodent Temporomandibular Joint by Targeting Chondrocyte CaSR.

Authors:  Mian Zhang; Hongxu Yang; Xianghong Wan; Lei Lu; Jing Zhang; Hongyun Zhang; Tao Ye; Qian Liu; Mianjiao Xie; Xiaodong Liu; Shibin Yu; Shaoxiong Guo; Wenhan Chang; Meiqing Wang
Journal:  J Bone Miner Res       Date:  2019-01-07       Impact factor: 6.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.